Premium Information is available for this item - Upgrade for $1 a day
6505-01-052-2855
Usp Warfarin Sodium Tablets
6505010522855 010522855 COUMADIN 56-0174-75
INC: 27974 Warfarin Sodium Tablets
November 2023
8
Marketplace 6505-01-052-2855
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-052-2855 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-052-2855 RQST Updated Every Day 6505-01-052-2855 RQST NE Related Documents
6505-01-052-2855 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-052-2855
TABLETS COUMADIN NDC00056-0174-70 Managed by United States NSN Created on 14 Mar 1972 Data Last Changed
Usp Warfarin Sodium Tablets 6505004822725 Warfarin Sodium Tablets 6505010522855 COUMADIN https/ Usp
COUMADIN TABLETS NDC00056-0176-70 Managed by United States NSN Created on 1 Jan 1961 Data Last Changed
Tablets6505007282616 007282616COUMADINCOUMADIN TABLETSNDC00056-0176-70 Managed by United States COUMADIN
COUMADIN TABLETS NDC00056-0174-75 Managed by United States NSN Created on 13 Oct 1977 Data Last Changed
TABLETS NDC00056 -0176-70 Managed by United States NSN Created on 1 Jan 1961 Data Last Changed COUMADIN
COUMADIN TABLETS NDC76282-0328-01 NDC60429-0785-01 NDC51672-4028-01 Managed by United States NSN Created
TABLETS NDC00056-0176-70 Managed by United States NSN Created on 1 Jan 1961 Data Last Changed COUMADIN
Restrictions 6505-01-052-2855
6505-01-052-2855 is a Usp Warfarin Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-052-2855
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-052-2855
- Part Number
- Manufacturer
- Status
- 56-0174-75
- Manufacturer
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Primary Buy
- Primary Buy
- COUMADIN
- 04490 - Bristol-Myers Squibb Pharma Company (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-052-2855
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 10.000 Milligrams Warfarin Sodium Active Ingredient
- Primary Container Type [CQCT]
- Strip
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
- Total Primary Container Quantity [CSCW]
- 1
Similar Supply Items to 6505-01-052-2855
Freight Information 6505-01-052-2855
6505-01-052-2855 has freight characteristics.. 6505-01-052-2855 has a variance between NMFC and UFC when transported by rail and the description should be consulted.